These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19237811)

  • 41. Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Lucreziotti S; Centola M; Salerno-Uriarte D; Ponticelli G; Battezzati PM; Castini D; Sponzilli C; Lombardi F
    Int J Cardiol; 2014 Jun; 174(1):37-42. PubMed ID: 24698233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of Contrast-Induced Nephropathy With Persistent Renal Dysfunction and Adverse Long-term Outcomes in Patients With Acute Myocardial Infarction Using the Mehran Risk Score.
    Wi J; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Ha JW; Hong MK; Jang Y
    Clin Cardiol; 2013 Jan; 36(1):46-53. PubMed ID: 23027701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contrast induced nephropathy in diabetic and non-diabetic patients during coronary angiogram and angioplasty.
    Rahman MM; Haque HS; Banerjee SK; Ahsan SA; Rahman MF; Mahmood M; Salman M; Azam MG
    Mymensingh Med J; 2010 Jul; 19(3):372-6. PubMed ID: 20639829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.
    Kanbay M; Siriopol D; Ozdogan E; Afsar B; Ertuglu LA; Grigore M; Sag AA; Kuwabara M; Lanaspa MA; Ortiz A; Johnson RJ; Covic A
    Int Urol Nephrol; 2020 Mar; 52(3):541-547. PubMed ID: 32008199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.
    Raposeiras-Roubín S; Abu-Assi E; Ocaranza-Sánchez R; Alvarez-Álvarez B; Cambeiro-González C; Fandiño-Vaquero R; García-Castelo A; García-Acuña JM; González-Juanatey JR
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):888-97. PubMed ID: 23362013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Two Risk Models in Predicting the Incidence of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention.
    Araujo GN; Wainstein MV; McCabe JM; Huang PH; Govindarajulu US; Resnic FS
    J Interv Cardiol; 2016 Oct; 29(5):447-453. PubMed ID: 27377243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
    Iakovou I; Dangas G; Mehran R; Lansky AJ; Ashby DT; Fahy M; Mintz GS; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    J Invasive Cardiol; 2003 Jan; 15(1):18-22. PubMed ID: 12499523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention.
    Marenzi G; De Metrio M; Rubino M; Lauri G; Cavallero A; Assanelli E; Grazi M; Moltrasio M; Marana I; Campodonico J; Discacciati A; Veglia F; Bartorelli AL
    Am Heart J; 2010 Dec; 160(6):1170-7. PubMed ID: 21146674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrast-induced nephropathy in urgent coronary interventions.
    Valente S; Lazzeri C; Giglioli C; Margheri M; Comeglio M; Nicolaci L; Chechi T; Gensini GF
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):737-41. PubMed ID: 17001234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention.
    Victor SM; Gnanaraj A; S V; Deshmukh R; Kandasamy M; Janakiraman E; Pandurangi UM; Latchumanadhas K; Abraham G; Mullasari AS
    Indian Heart J; 2014; 66(5):517-24. PubMed ID: 25443605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical survey on contrast-induced nephropathy after coronary angiography.
    Wang F; Li J; Huang B; Zhao Q; Yu G; Xuan C; Wei M; Wang N
    Ren Fail; 2013 Oct; 35(9):1255-9. PubMed ID: 23944863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of contrast media on kidney function in patients with stable coronary artery disease.
    Reuter SB; Harutyunyan M; Mygind ND; Jørgensen E; Kastrup J
    Scand Cardiovasc J; 2014 Aug; 48(4):234-40. PubMed ID: 24941300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
    Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.
    Wang YB; Fu XH; Gu XS; Wang XC; Zhao YJ; Hao GZ; Jiang YF; Fan WZ; Wu WL; Li SQ; Xue L
    Chin Med J (Engl); 2012 Mar; 125(6):1063-7. PubMed ID: 22613532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
    Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
    Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel risk assessment model of contrast-induced nephropathy after percutaneous coronary intervention in patients with diabetes.
    Yao ZF; Shen H; Tang MN; Yan Y; Ge JB
    Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):305-314. PubMed ID: 32991776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention.
    Shehata M
    Am J Cardiol; 2014 Aug; 114(3):389-94. PubMed ID: 24927970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of a predictive risk score for radiocontrast-induced nephropathy following percutaneous coronary intervention.
    Skelding KA; Best PJ; Bartholomew BA; Lennon RJ; O'Neill WW; Rihal CS
    J Invasive Cardiol; 2007 May; 19(5):229-33. PubMed ID: 17476039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterization.
    Capodanno D; Ministeri M; Dipasqua F; Dalessandro V; Cumbo S; Gargiulo G; Tamburino C
    J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):524-9. PubMed ID: 25304032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.